APA (7th ed.) Citation

B, B., J, M., S, F., M, D., R, R., M, D., . . . WF, R. (2026). Clinical Qualification of Subcutaneous Injection Devices for Monoclonal Antibodies. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy, 40(1), 5. https://doi.org/10.1007/s40259-025-00755-9

Chicago Style (17th ed.) Citation

B, Bittner, Munoz J, Frank S, Dolton M, Ravanello R, Dembowski M, Clement A, and Richter WF. "Clinical Qualification of Subcutaneous Injection Devices for Monoclonal Antibodies." BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy 40, no. 1 (2026): 5. https://doi.org/10.1007/s40259-025-00755-9.

MLA (9th ed.) Citation

B, Bittner, et al. "Clinical Qualification of Subcutaneous Injection Devices for Monoclonal Antibodies." BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy, vol. 40, no. 1, 2026, p. 5, https://doi.org/10.1007/s40259-025-00755-9.